Equity
€388,801 ▲ 48.0%
TAKOR has made a profit without a break since 2018.
TAKOR
Lifetime
19 annual accounts with figures on one time axis, 21 filings since 2005peak €262,724 (2025)
€262,724▲ 47.6%
lowest -€2,173 (2017)
€160,072▲ 49.5%
peak €388,801 (2025)
€388,801▲ 48.0%
€68,001▼ 61.9%
Board1 name since 2022
1 director
Documentsfilings and deeds
16-12-202546 days before the deadline
2025micro format
Gross margin from €178,054 to €262,724Result from €107,081 to €160,072Dividend €34,000Equity from €262,730 to €388,801Debts from €178,689 to €68,001Cash from €182,983 to €280,379
Key points
from the 2025 annual accountsResult
€160,072 ▲ 49.5%
The result rose in 2025 from €107,081 to €160,072.
Turnover
≈ €400,000 estimated
The micro format states no turnover.
Liquidity
4.65 was 1.51 in 2024
Short-term debts fell from €178,459 to €66,943.
Filings
21 annual accounts since 2005
The last five annual accounts were filed 6 to 57 days before the end of the period.
Position in the sector
€160,072
Higher net result than 82% of companies in human health. Sector median €59,563 · 21,309 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 20,135 companies had the same profile as TAKOR has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,135 companies, not a prediction for TAKOR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0865760335
Registered office moved within Waterloo
New registered office: Avenue Lord Uxbridge 1 à 1410 Waterloo · Previous registered office: Avenue de l'Eté, 50 1410 Waterloo · Gazette deed
Change of role: , from manager to director
Permanent representative: · General meeting of 16-06-2023 · Gazette deed
Incorporation
published on 22-06-2004 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| TAKOR Waterloo | €456,802 | €262,724 | 85.1% | - |
| DEKA MEDIC Court-Saint-Etienne | €402,506 | €247,246 | 37.6% | - |
| DR.S. DE HERTOG Zaventem | €450,064 | €251,779 | 49.5% | - |
| DR. WILDIERS ANTOON Lier | €452,807 | €244,482 | 88.4% | - |
| Dr. S. Hauglustaine Hasselt | €464,301 | €271,293 | 1.1% | - |
| Dr.Isabelle VAN MIEGHEM,radioloog Hasselt | €472,990 | €291,503 | 60.1% | 1.7 |
| ORTHOGER Genappe | €536,412 | €232,997 | 90.6% | - |
These companies have the same main activity as TAKOR: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €403,000 and €536,000, founded between 2003 and 2006.
Official details
Source: KBO- Status
- Active since 14-06-2004Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.234.838.3291410 Waterloo, since 02-06-2004
- Financial year end
- 30 June
- Peppol
- Reachable since 06-02-2026
Annual accounts to 30-06-2025
- €456,802▲ 3.5%
- Filing
- Filed on 16-12-2025, 46 days before the end of the filing period
Insights on TAKOR
TAKOR files the micro format. That format states no turnover. The gross margin rose from €80,467 in 2007 to €262,724 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about TAKOR
- What is the company number of TAKOR?
- The company number of TAKOR is 0865.760.335. The VAT number is the same number with BE in front: BE 0865.760.335.
- Where is TAKOR based?
- The registered office is at Avenue Lord Uxbridge 1, 1410 Waterloo.Company details
- What does TAKOR do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of TAKOR?
- TAKOR is a private limited company (BV).
- When was TAKOR founded?
- TAKOR was founded on 14-06-2004.
- Is TAKOR still active?
- Yes, TAKOR is an active enterprise in the KBO register.
- What is the turnover of TAKOR?
- The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €262,724 and 31 comparable companies (NACE 86220). It probably lies between €350,000 and €550,000.Financials
- Is TAKOR profitable?
- In financial year 2025, TAKOR made a profit of €160,072.
- Where can I find the annual accounts of TAKOR?
- TAKOR filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of TAKOR due?
- TAKOR must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.